Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients

Overview of attention for article published in Cochrane database of systematic reviews, June 2014

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 7 tweets from 7 users, with an upper bound of 25,424 followers.

@hswapnil @nupur_nephron @PD_Perls @eric_weinhandl @NephJC @OttawaRenal Not that wishy washy. Agree that loop should probably be first, but why spironolactone before ACEi? Too much hypokalemia? #Nephjc https://t.co/wjgCrOIs6g https://t.co/3fqoUMtkyd

@nephron84 don't believe those small Japanese trials in PD - or the Cochrane SR either (https://t.co/qWCWqfyM20) Also see https://t.co/0dgaDJAh5l Use ARBs for BP or CV indications perhaps. Not for RRF preservation (PD or HD)

@docpro89 @Maximal_Change @Errantnephron @askrenal @NephJC @STOPACEi_trial Yes definitely use RAAS blockade to preserve residual kidney function 👍👍 On a related note, you do still need to watch out for hyperkalemia in ESRD patients as RAASi can mess with g

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 3 additional tweets.